Synergy Spine Solutions announced today that it received FDA premarket approval (PMA) for its Synergy Disc for 1-level indications at C3-C7.
The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.
Milestone approval advances a new category of artificial cervical disc technology uniquely engineered to preserve motion and improve spinal ...
Undergoing Cervical Spine Surgery with the Salt Lake Orthopedic Clinic at MountainStar Healthcare’s St. Mark’s Hospital ...
Advanced imaging and neurological-focused evaluation are gaining attention among patients with migraines, vertigo, and ...
Inflammatory and structural abnormalities may be common in the axial skeleton among patients with axial spondyloarthritis.
Researcher found 80% of claim denials were ultimately reversed, reinforcing long-standing concerns raised by AAOS and patient advocates ...
In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," reviews some Winter Olympic mishaps. Varshavski: I've reacted ...
A spine surgeon who practiced in Longview is facing four malpractice lawsuits from patients who said he botched their surgeries, leaving them with long-term disabilities. However, in a lawsuit against ...
Dymicron®, a privately held medical device company advancing next-generation spinal motion-preservation technology, today announced the appointment of Peter Wehrly, one of the spinal industry's most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results